There’s Only 1 Stock I’d Buy Right Now for Positive Momentum
The Motley Fool
Published Dec 31, 0000 19:00
Updated Sep 18, 2018 00:02
Capital gains investors are in luck today if they happen to be looking for a healthcare-related stock on a tear. The following natural health product manufacturer is today’s breakout stock, with a rapidly rising share price that momentum and capital gains investors should jump on before it’s too late.
It’s also a high-quality dividend stock, meaning that several different investment styles can be covered with just one pick. However, what it is not is a value stock. But should wild market fundamentals put you off some sweet upside, or a potential TFSA stocking filler? Let’s dive into some figures and find out.
Jamieson Wellness (TSX:JWEL)
This popular stock often gets some glowing write-ups as a strong buy for tax-free savings accounts; its positive momentum also makes it a good choice for anyone hunting upside. In case you don’t know, Jamieson Wellness produces natural health products on a global scale, and is involved with their marketing as well as their development and manufacture.
How does this stock fare on market fundamentals, though? Overvalued by about a dollar a share compared to its future cash flow value, it’s about where it should be in that regard. However, a P/E of 208.2 times earnings tells a different story, with a PEG ratio of 4.7 times growth confirming high overvaluation. A P/B of 4.4 times book is actually fairly good for the Canadian personal products industry, though of course this is not ideal compared to the market.
Growth investors should take note that a 44.5% expected annual growth in earnings is on the cards over the next 1 to 3 years. While its debt level of 77.2% of net worth is significant, it’s certainly not the worst on the TSX, though a return on equity of 6% last year could be better. A dividend yield of 1.4% adds to the quality of this stock, while a steep upward trend of Jamieson Wellness’ share price at the moment makes it a very strong contender for momentum investors.
If you are looking for competitors, Pfizer (NYSE:PFE), Procter & Gamble, and Costco Wholesale (NASDAQ:COST) would be the closest analogies.
The JWEL in your crown?
To make a ticker-based pun, this stock could be the JWEL in the crown of your momentum investment portfolio right now. Joking aside, the positive momentum offered by this stock means that capital gains investors have a clear opportunity to cash in by riding the updraft of its share price. It also adds to the overall buy signal that most stock screening tools would return for Jamieson Wellness at the moment.
Get The App
Another good indicator of self-confidence in this stock is the fact that over the last 12-month period, more shares have been purchased than sold by insiders. While this doesn’t tell us too much about the quality of this stock on its own, this fact goes some way towards its current “buy” status.
The bottom line
For capital growth plus a dividend, you’re likely in good hands with this stock. It’s high-quality and has cornered a growth market. In terms of positive momentum, you can’t do better at the moment. In short, this is a rare stock that should satisfy both passive income investors looking to line a TFSA or RRSP and capital gains investors looking to ride a rising share price.
Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.